» Articles » PMID: 12726713

Comparison of Human Bone Marrow Stromal Cells Seeded on Calcium-deficient Hydroxyapatite, Beta-tricalcium Phosphate and Demineralized Bone Matrix

Overview
Journal Biomaterials
Date 2003 May 3
PMID 12726713
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to compare three resorbable biomaterials regarding seeding efficacy with human bone marrow stromal cells (BMSCs), cell penetration into the matrix, cell proliferation and osteogenic differentiation. Calcium-deficient hydroxyapatite (CDHA), beta-tricalcium phosphate (beta-TCP), and demineralized bone matrix (DBM) were seeded with human BMSCs and kept in human serum and osteogenic supplements for 3 weeks. Morphologic and biochemical evaluations were performed on day 1, 7, 14 and 21. The allograft DBM and CDHA exhibited both an excellent seeding efficacy while the performance of beta-TCP was lower when compared. The total protein content and the values for specific alkaline phosphatase (ALP) increased on all matrices and no significant difference was found for these two markers. BMSCs in monolayer had a significant increase of protein, but not of ALP. Osteocalcin (OC) values increased significantly higher for BMSC in cultures on DBM when compared to CDHA and beta-TCP. The OC levels decreased significantly in the BMSC monolayer culture. BMSCs were found inconsistently within the synthetic materials, whereas in DBM they were found more homogeneously distributed throughout the matrix. All three matrices promoted BMSC proliferation and differentiation to osteogenic cells. DBM allografts seem to be more favorable with respect to cell ingrowth tested by histology, and osteogenic differentiation ascertained by an increase of OC. CDHA with its high specific surface area showed more favorable properties than beta-TCP regarding reproducibility of the seeding efficacy.

Citing Articles

1,25(OH)2D3 increase osteogenic potential of human periodontal ligament cells with low osteoblast potential.

Pereira B, Sacramento C, Sallum E, Monteiro M, Casarin R, Casati M J Appl Oral Sci. 2024; 32:e20240160.

PMID: 39607248 PMC: 11657088. DOI: 10.1590/1678-7757-2024-0160.


Sintered fluorapatite scaffolds as an autograft-like engineered bone graft.

Nielson C, Agarwal J, Beck J, Shea J, Jeyapalina S J Biomed Mater Res B Appl Biomater. 2024; 112(2):e35374.

PMID: 38359170 PMC: 11827050. DOI: 10.1002/jbm.b.35374.


In Vivo Evaluation of Bone Regenerative Capacity of the Novel Nanobiomaterial: β-Tricalcium Phosphate Polylactic Acid-co-Glycolide (β-TCP/PLLA/PGA) for Use in Maxillofacial Bone Defects.

Ramanathan M, Shijirbold A, Okui T, Tatsumi H, Kotani T, Shimamura Y Nanomaterials (Basel). 2024; 14(1).

PMID: 38202548 PMC: 10780666. DOI: 10.3390/nano14010091.


Evaluation of Biphasic Calcium Phosphate Scaffolds Derived from Cuttlefish Bone Coated with Poly(ester urea) for Bone Tissue Regeneration.

Pereira P, S Neto A, Rodrigues A, Barros I, Miranda C, Ramalho-Santos J Polymers (Basel). 2023; 15(10).

PMID: 37242831 PMC: 10220552. DOI: 10.3390/polym15102256.


Urine-derived stem cells: applications in skin, bone and articular cartilage repair.

Zhang W, Hu J, Huang Y, Wu C, Xie H Burns Trauma. 2021; 9:tkab039.

PMID: 34859109 PMC: 8633594. DOI: 10.1093/burnst/tkab039.